Dashboard
Manage Tickers

ESPR Esperion Therapeutics, Inc.

Nasdaq esperion.com


$ 2.59 $ 0.05 (1.98 %)    

Thursday, 16-Oct-2025 13:15:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 601.68 $ -3.53 (-0.58 %)
DIA $ 461.11 $ -2.26 (-0.49 %)
SPY $ 662.89 $ -4.03 (-0.6 %)
TLT $ 91.25 $ 0.76 (0.84 %)
GLD $ 394.76 $ 3.60 (0.92 %)
$ 2.52
$ 2.54
$ 2.58 x 2,645
$ 2.59 x 2,241
$ 2.53 - $ 2.58
$ 0.69 - $ 3.94
9,042,433
na
508.09M
$ 1.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-07-2025 01-01-1970 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-07-2024 03-31-2024 10-Q
7 02-27-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-01-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 02-21-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-02-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-22-2022 12-31-2021 10-K
16 11-02-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 02-23-2021 12-31-2020 10-K
20 11-02-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-27-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-20-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-08-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 02-22-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-04-2016 03-31-2016 10-Q
39 02-25-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

esperion-nominates-esp-2001-as-preclinical-development-candidate-for-primary-sclerosing-cholangitis
Esperion Nominates ESP-2001 As Preclinical...
10/16/2025 12:05:36

– Highly-Specific Allosteric ACLY Inhibitor Designed to Target Liver and Bile Duct Injury, Inflammation, and Fibrosis Associate...

dow-jumps-over-100-points-us-crude-oil-inventories-increase
Dow Jumps Over 100 Points; US Crude Oil In...
10/08/2025 17:22:50

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/08/2025 17:06:09

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/08/2025 12:09:23

penguin-solutions-posts-q4-earnings-joins-esperion-therapeutics-joby-aviation-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Penguin Solutions Posts Q4 Earnings, Joins...
10/08/2025 12:01:10

why-confluent-shares-are-trading-higher-by-around-20-here-are-20-stocks-moving-premarket
Why Confluent Shares Are Trading Higher By...
10/08/2025 08:43:58

reported-earlier-esperion-therapeutics-prices-30m-common-share-offering-at-250-per-share-for-gross-proceeds-of-75m
Reported Earlier, Esperion Therapeutics Pr...
10/08/2025 06:55:52

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/07/2025 21:06:58

esperion-announces-proposed-public-offering-of-common-stock-terms-not-disclosed
Esperion Announces Proposed Public Offerin...
10/07/2025 20:03:27

Esperion Therapeutics, Inc. ("Esperion") (NASDAQ:ESPR), a commercial stage biopharmaceutical company that focuses on de...

esperion-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-1603
Esperion Therapeutics Shares Halted On Cir...
10/03/2025 13:58:33

Core News & Articles
Esperion, Dr. Reddy's Laboratories Reach P...
10/03/2025 12:04:05

ANN ARBOR, Mich., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ:ESPR) today announced that it has entered into a settlemen...

hc-wainwright--co-reiterates-buy-on-esperion-therapeutics-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Espe...
09/19/2025 13:23:32

HC Wainwright & Co. analyst Joseph Pantginis reiterates Esperion Therapeutics (NASDAQ:ESPR) with a Buy and maintains $16...

esperions-nexletol-partner-otsuka-receives-approval-in-japan-to-market-nexletol-for-treatment-of-hypercholesterolemia
Esperion's NEXLETOL Partner, Otsuka, Recei...
09/19/2025 12:01:54

top-2-health-care-stocks-that-may-plunge-this-month
Top 2 Health Care Stocks That May Plunge T...
09/05/2025 14:39:30

esperions-bempedoic-acid-receives-level-1a-recommendation-in-updated-guidelines-from-european-society-of-cardiology-and-european-atherosclerosis-society
Esperion's Bempedoic Acid Receives Level 1...
08/29/2025 12:05:19

esperion-therapeutics-q2-eps-002-beats-014-estimate-sales-82385m-beat-63142m-estimate
Esperion Therapeutics Q2 EPS $(0.02) Beats...
08/05/2025 10:01:59

Esperion Therapeutics (NASDAQ:ESPR) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

what-to-expect-from-esperion-therapeuticss-earnings
What to Expect from Esperion Therapeutics'...
08/04/2025 21:02:22

watching-esperion-therapeutics-traders-circulate-social-media-unconfirmed-rumors-that-the-stock-is-seeing-takeover-interest-in-the-900m-range
Watching Esperion Therapeutics; Traders Ci...
07/24/2025 16:48:58

esperion-reaches-settlement-with-accord-healthcare-to-delay-us-launch-of-generic-nexletol-until-at-least-april-2040
Esperion Reaches Settlement With Accord He...
07/08/2025 12:19:38

Esperion (NASDAQ:ESPR) today announced that it has entered into a settlement agreement with Accord Healthcare Inc. This agreeme...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION